News

Government unveils £8M OpenBind consortium to lead in AI drug discovery | Project to build world’s largest drug–protein ...
Judges uphold PTAB’s finding that two Agilent patents are invalid | All claims of patents, which cover guide RNAs, found to ...
Three seasoned lawyers with experience in biotech, pharmaceutical, and medical device patent matters join the firm's practice ...
Unified Patent Court announces new case management system this summer | Release will be in two phases, with first phase ...
Two decisions by acting USPTO director Coke Morgan Stewart have “damaging” consequences, warns Vidal | Stewart kickstarts campaign of implied criticism of predecessor’s record. Already registered?
Two years since the UPC opened its doors, various developments might influence the UK government to reassess its position, ...
US appeals court confirms validity of Acadia's Nuplazid patents | Decision fends off generics from MSN Laboratories and ...
The LSPN Europe 2025 Survey, which comes ahead of LSPN Europe in London in November, invites patent practitioners ...
The new hire brings over 20 years of experience in patent prosecution and litigation involving pharmaceuticals, molecular ...
The firm’s new practice unites Faber’s transactional and licensing abilities with Crowell’s regulatory and litigation ...
A new law affecting disputes concerning the ‘Bolar provision’ could allow competitors to enter the Ukrainian market before a ...
15 April 2025 Court hears arguments from J&J and Teva to determine whether a patent blocking generic versions of Invega ...